Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC	Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, biliary tract cancer, biliary tract disorder, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Recruiting	Phase 2	2026-04-02		NCT05733598

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Replimune, Inc.	14

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beverly Hills Cancer Center	Beverly Hills	United States	26
Houston Methodist Hospital Cancer Center	Houston	United States	5
Moffitt Cancer Center	Tampa	United States	523
Montefiore Medical CenterMontefiore Medical Park	The Bronx	United States	1
Roswell Park Comprehensive Cancer Center	Buffalo	United States	1
Sylvester Comprehensive Cancer Center (University of Miami Hospital and Clinics)	Miami	United States	1
The West Clinic	Germantown	United States	9
UC San Diego Moores Cancer Center	La Jolla	United States	22
University of Maryland Medical Center	Baltimore	United States	87
University of Pennsylvania, Abramson Cancer Center	Philadelphia	United States	12
University of Tennessee Medical Center	Knoxville	United States	54
UPMC Hillman Cancer Center	Pittsburgh	United States	330